ADDvise receives order worth 1,9 MSEK
ADDvise Group AB’s (publ) newly acquired subsidiary Hettich Labinstrument has received an order from Region Norrland. The order is for a delivery of an automatic inoculation and streaking robot to Laboratoriemedicin Mikrobiologen.
The automatic inoculation and streaking robot will help the staff so that they can engage in more qualified work. Further on, the robot will also be able to take part in a larger automatic system with incubation and imaging.
The order is worth approximately 1,9 MSEK and will be delivered in May.
– I am certain that this is the first of many positive news that Hettich Labinstrument will contribute with, says Rikard
Akhtarzand CEO for ADDvise Group AB concerning the order.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on March 9th, 2017 at 11:15 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.